J.J. Gout-Zwart, MSc

No picture available
E-mail:
j.j.gout-zwart umcg.nl

Research

Publications
  1. COST-EFFECTIVENESS OF INTRODUCING A DIETARY INTERVENTION FOR RENAL TRANSPLANT RECIPIENTS

    Gout-Zwart, J., Coerts, F., Gruppen, E., Gomes-Neto, A., van der Veen, Y., Oste, M., Bakker, S. & Postma, M., Nov-2019, In : Value in Health. 22, S3, p. S915-S915 1 p., PUK13.

    Research output: Contribution to journalMeeting AbstractAcademic

  2. Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands

    Gout-Zwart, J. J., de Jong, L. A., Saptenno, L. & Postma, M. J., Jun-2020, In : PharmacoEconomics - open. 4, 2, p. 321-330 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands: A systematic review

    van Schoonhoven, A. V., Gout-Zwart, J. J., de Vries, M. J. S., van Asselt, A. D. I., Dvortsin, E., Vemer, P., van Boven, J. F. M. & Postma, M. J., 6-Sep-2019, In : PLoS ONE. 14, 9, 22 p., e0221856.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Rivaroxaban for non-valvular atrial fibrillation and venous thromboembolism in the Netherlands: a real-world data based cost-effectiveness analysis

    de Jong, L. A., Gout-Zwart, J. J., van den Bosch, M., Koops, M. & Postma, M. J., 3-Apr-2019, In : Journal of Medical Economics. 22, 4, p. 306-318 13 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands: Clinical and Economic Effects

    De Jong, L. A., Gout-Zwart, J. J., Stevanovic, J., Rila, H., Koops, M., Huisman, M. V. & Postma, M. J., 30-Dec-2018, In : BMJ Open. 2, 3, p. e315-e324 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (12) »

ID: 38980907